Quartz reports on a large study suggesting weight loss drugs may reduce psychiatric hospital visits among people with schizophrenia.
Recap by typeshit. Post by Quartz on X.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
Trials show no overall rise in cancer with GLP-1 drugs, OncoDaily says, but thyroid cancer is still a watch point and long-term effects remain unclear.
A short social post says fast weight loss on Ozempic may bring temporary hair shedding and that care can help, with few details beyond that.
Loading…